Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settings
- 14 November 2006
- journal article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 15 (5), 497-503
- https://doi.org/10.1007/s00520-006-0173-z
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Incidence of chemotherapy‐induced nausea and emesis after modern antiemeticsCancer, 2004
- Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5‐hydroxytryptamine‐3 antiemeticsCancer, 2003
- Delayed Chemotherapy-Induced Nausea in Women Treated for Breast CancerOncology Nursing Forum, 2003
- A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesisCancer Chemotherapy and Pharmacology, 1996
- Frequency and Clinical Implications of Delayed Nausea and Delayed EmesisAmerican Journal of Clinical Oncology, 1996
- On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993Annals Of Oncology, 1996
- Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patientsEuropean Journal of Cancer, 1992
- Predictive Factors of Delayed Emesis in Cisplatin-Treated Patients and Antiemetic Activity and Tolerability of Metoclopramide or DexamethasoneAmerican Journal of Clinical Oncology, 1991
- Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and VomitingAnnals of Internal Medicine, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990